Home > SWOT Analysis > Akorn (AKRX) SWOT Analysis





Akorn (AKRX) SWOT Analysis Profile

Akorn, Inc., founded in 1971, manufactures pharmaceutical products in four segments. Diagnostic and therapeutic ophthalmic products are offered through the Ophthalmic segment. Injectable drugs including anesthesia and pain management products are offered through the Hospital Drugs and Injectables segment. Tetanus-Diptheria vaccines are available through the Biologics and Vaccines segment. The Contract Services segment manufactures products for pharmaceutical and bioTechnology customers. Headquartered in Buffalo Grove, Illinois, Akorn serves physicians, hospitals, and pharmaceutical companies among others. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 0

Threats + Weaknesses = 1

… The ability to capitalize on opportunities get rewarded with higher profits and lower costs.